ArticleBriefings in bioinformatics2025
Chrombus-XMBD: a graph convolution model predicting 3D-genome from chromatin features.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The 3D conformation of the chromatin is crucial for transcriptional regulation. However, current experimental techniques for detecting the 3D structure of the genome are costly and limited to the biological conditions. Here, we described "ChrombusXMBD," a graph convolution model capable of predicting chromatin interactions ab initio based on available chromatin features. Using dynamic edge convolution with multihead attention mechanism, Chrombus encodes the 2D-chromatin features into a learnable embedding space, thereby generating a genome-wide 3D-contactmap. In validation, Chrombus effectively recapitulated the topological associated domains, expression quantitative trait loci, and promoter/enhancer interactions. Especially, Chrombus outperforms existing algorithms in predicting chromatin interactions over 1-2 Mb, increasing prediction correlation by 11.8%-48.7%, and predicts long-range interactions over 2 Mb (Pearson's coefficient 0.243-0.582). Chrombus also exhibits strong generalizability across human and mouse-derived cell lines. Additionally, the parameters of Chrombus inform the biological mechanisms underlying cistrome. Our model provides a new, generalizable analytical tool for understanding the complex dynamics of chromatin interactions and the landscape of cis-regulation of gene expression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.